Canada markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
107.59+0.52 (+0.49%)
At close: 04:00PM EDT
107.50 -0.09 (-0.08%)
After hours: 07:54PM EDT

Abbott Laboratories

100 Abbott Park Road
Abbott Park
North Chicago, IL 60064-6400
United States
224 667 6100
https://www.abbott.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees114,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert B. FordChairman of the Board, President & CEO4.73M6.64M1974
Mr. Philip P. BoudreauCFO & Senior VP of Finance1.14MN/A1973
Mr. Hubert L. AllenExecutive VP, General Counsel & Secretary2MN/A1966
Mr. Robert E. Funck Jr.Executive Vice President of Finance2.18MN/A1961
Mr. Daniel Gesua Sive SalvadoriExecutive VP and Group President of Established Pharmaceuticals & Nutritional Products1.76MN/A1979
Ms. Lisa D. EarnhardtExecutive VP & Group President of Medical Devices1.73MN/A1970
Ms. Sabina EwingSenior VP of Business & Technology Services and Chief Information OfficerN/AN/A1974
Erica L. BattagliaVP and Chief Ethics & Compliance OfficerN/AN/AN/A
Ms. Melissa BrotzVice President of Public Affairs & Corporate MarketingN/AN/AN/A
Mr. Christopher J. ScogginsSenior Vice President of Commercial Operations, Marketing & Diabetes CareN/AN/A1970
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Corporate Governance

Abbott Laboratories’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 8; Board: 5; Shareholder Rights: 2; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.